Clinical Trial Update: A First in Human Study of AUR 103 Calcium to Evaluate Safety, Pharmacokinetics and Pharmacodynamics [Phase 1]

View source ↗

Summary

First-in-human Phase 1 study of AUR 103 Calcium to evaluate safety, pharmacokinetics, and pharmacodynamics in adults with acute myeloid leukemia, myelodysplasti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes
• Non-hodgkin Lymphoma

Drugs mentioned

• AUR 103 Calcium

Snippet

Sponsor: Aurigene Discovery Technologies Limited | Conditions: Solid Tumor, Adult, Acute Myeloid Leukemia | Phase 1 | Status: TERMINATED